Lamivudine and adefovir resistance in children and young adults with chronic hepatitis B
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, cilt.14, sa.3, 2010 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 14 Sayı: 3
- Basım Tarihi: 2010
- Doi Numarası: 10.1016/j.ijid.2009.04.002
- Dergi Adı: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Anahtar Kelimeler: Lamivudine, Adefovir, Resistance, Hepatitis B
- Dokuz Eylül Üniversitesi Adresli: Hayır
Özet
Objective: Long-term lamivudine (LAM) and adefovir (ADV) treatment has been found to induce the emergence of drug-resistant hepatitis B virus (HBV) in a significant number of patients with chronic hepatitis B (CHB) infection. The aim of our study was to evaluate the LAM and ADV mutations detected in our patient group.